KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Non-Current Debt (2016 - 2025)

Elevance Health (ELV) has disclosed Non-Current Debt for 17 consecutive years, with $31.2 billion as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Debt rose 26.27% to $31.2 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $31.2 billion, a 26.27% increase, with the full-year FY2024 number at $29.2 billion, up 25.69% from a year prior.
  • Non-Current Debt was $31.2 billion for Q3 2025 at Elevance Health, up from $28.2 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $31.2 billion in Q3 2025 to a low of $19.9 billion in Q1 2022.
  • A 5-year average of $24.1 billion and a median of $23.2 billion in 2023 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: fell 12.8% in 2024, then increased 27.91% in 2025.
  • Elevance Health's Non-Current Debt stood at $21.2 billion in 2021, then grew by 5.63% to $22.3 billion in 2022, then grew by 4.01% to $23.2 billion in 2023, then grew by 25.69% to $29.2 billion in 2024, then rose by 6.69% to $31.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Non-Current Debt are $31.2 billion (Q3 2025), $28.2 billion (Q2 2025), and $28.1 billion (Q1 2025).